ADGMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Adagio Medical Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026

$0.12+0.02 (+21.21%)

Close on Oct 19, 2026

Market cap: $2.67M
P/E (TTM): –
Dividend yield: –

Adagio Medical Holdings, Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31
Revenue	0	–	0.30
Cost of Revenue	0.68	–	1.31
Gross Profit	-0.68	–	-1.01
Research & Development	11	–	15
Selling, General & Admin	11	–	12
Total Costs & Expenses	22	–	28
Operating Income	-22	–	-28
Interest Expense	2.91	–	1.66
Interest & Investment Income	0.48	–	0.00
Other Non-Operating Income	-3.19	–	-8.65
Asset Impairment Charges	0	–	0
Gain (Loss) on Sale of Assets	–	–	0.00
Pretax Income	-25	–	-37
Income Tax Expense	0	0	0
Net Income incl. Noncontrolling Interests	-25	–	-37
Net Income	-25	–	-37
Net Income to Common	-25	–	-37
EPS (Basic)(per share)	-1.51	–	-48.16
EPS (Diluted)(per share)	-1.51	–	-48.16
Shares Outstanding (Basic, Weighted)(shares)	17	–	0.76
Shares Outstanding (Diluted, Weighted)(shares)	17	–	0.76
Dividend per Share(per share)	–	–	0.00
EBITDA	-21	–	-27

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: -155.3%

Financial strength

Current ratio: 1.41
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 102.4%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –